ClinicalTrials.Veeva

Menu

Sensory Rehabilitation in Chemotherapy Induced Peripheral Neuropathy (CIPN)

S

Shamir Medical Center (Assaf-Harofeh)

Status

Enrolling

Conditions

CIPN

Treatments

Diagnostic Test: Questionares and practice

Study type

Interventional

Funder types

Other

Identifiers

NCT05382520
0057-22-ASF

Details and patient eligibility

About

Physiotherapist research about Sensory rehabilitation in chemotherapy induced peripheral neuropathy (CIPN) with the aid of questioners and physiotherapy practice

Enrollment

12 estimated patients

Sex

All

Ages

18 to 99 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Patients aged 18 and over who suffer from chemotherapy-induced neuropathy (CIPN), according to the patient's report, more than 3 months since the end of the chemotherapy treatment.

Exclusion criteria

  1. Sensory damage / neuropathy that existed even before the start of chemotherapy
  2. Incidents of recurrent falls even before the start of chemotherapy (over 2 falls for 6 months)
  3. Central nervous system involvement
  4. Major pre-morbid orthopedic lower limb impairment
  5. Hebrew language not sufficient for assessment and treatment

Trial design

Primary purpose

Other

Allocation

N/A

Interventional model

Single Group Assignment

Masking

None (Open label)

12 participants in 1 patient group

Explicit sensory retraining for lower extremity in individuals with CIPN
Experimental group
Description:
Explicit sensory retraining for lower extremity function (pain, sensory, balance, gait). five one-hour sessions, a week apart: Pre-Post assessment sessions with 3 treatment sessions in between. Home exercise assigned.
Treatment:
Diagnostic Test: Questionares and practice

Trial contacts and locations

1

Loading...

Central trial contact

Hadas Ofek; Nicole Asraf

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems